Richard M. Stone, MD

    Richard M. Stone, MD

    Chief of staff and director of the Adult Acute Leukemia Program at the Dana-Farber Cancer Institute in Boston, Massachusetts

    Drawing First Blood

    • FLT3 Inhibitors in Older Patients with Acute Myeloid Leukemia: More Questions Than Answers? Friday, July 1st, 2016

      Richard M. Stone, MDChief of staff and director of the Adult Acute Leukemia Program at the Dana-Farber Cancer Institute in Boston, MassachusettsSelina M. Luger, MDDirector of the Leukemia Program and professor of medicine at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia Acute myeloid leukemia (AML) affects primarily older adults (with a [...]

    back to top
    SHARE